Skip to main content
. 2018 Mar 23;62(2):236–263. doi: 10.20945/2359-3997000000032

Figure 4. Comparison of cabergoline (CAB) and bromocriptine (BCR), concerning efficacy and tolerability (Adapted from Ref. 34).

Figure 4